1. Babaei A, Katoonizadeh A, Ranjbar A, Naderi M, Ahmadbeigi N. Directly injected native bone-marrow stem cells cannot incorporate into acetaminophen-induced liver injury. Biologicals. 2018 Mar;52:55-58. doi: 10.1016/j.biologicals.2017.1006. Epub 2018 Jan 6.
  2. Aghayan HR, Arjmand B, Ahmadbeigi N, Gheisari Y, Vasei M. Draft of Iranian National Guideline for Cell Therapy Manufacturing. Arch Iran Med. 2017 Aug;20(8):547-550.
  3. Alatab S, Najafi I, Atlasi R, Pourmand G, Tabatabaei-Malazy O, Ahmadbeigi N. A systematic review of preclinical studies on therapeutic potential of stem cells or stem cells products in peritoneal fibrosis. Minerva Urol Nefrol. 2018 Apr;70(2):162-178. doi: 10.23736/S0393-2249.17.02882-X. Epub 2017 Mar 31.
  4. Samimi, Hilda, Parviz Fallah, Alireza Naderi Sohi, Rezvan Tavakoli, Mahmood Naderi, Masoud Soleimani, Bagher Larijani, and Vahid Haghpanah. "Precision medicine approach to anaplastic thyroid cancer: advances in targeted drug therapy based on specific signaling pathways." Acta medica Iranica 55, no. 3 (2017): 200-208
  5. Ayatollahi, Hossein, Mohammad Hadi Sadeghian, Mahmood Naderi, Amir Hossein Jafarian, Seyyede Fatemeh Shams, Neda Motamedirad, Maryam Sheikhi, Afsane Bahrami, and Sepideh Shakeri. "Quantitative assessment of Wilms tumor 1 expression by real-time quantitative polymerase chain reaction in patients with acute myeloblastic leukemia." Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences 22 (2017).
  6. Mahmood Naderi, Abdolreza Pazouki, Ehsan Arefian, Seyed Mahmoud Hashemi, Fatemeh Jamshidi-Adegani, Omid Gholamalamdari, Sara Soudi, Kayhan Azadmanesh, Siamak Mirab Samiee, Shahin Merat, Mohammad Gholami Fesharaki, Mahdieh Mondanizadeh, Mohammad Vasei, Masoud Soleimani. Two Triacylglycerol Pathway Genes, CTDNEP1 and LPIN1, are Down-Regulated by hsa-miR-122-5p in Hepatocytes. Archives of Iranian Medicine (AIM).2017
  7. Gheisari Y, Ahmadbeigi N. Mesenchymal Stem Cells and Endothelial Cells: A Common Ancestor? Arch Iran Med. 2016 Aug;19(8):584-7. doi: 0161908/AIM.0011.
  8. Sohrabi A, Naderi M, Gorjipour F, Ghamgosar A, Ahmadbeigi N. A new design for electrospinner collecting device facilitates the removal of small diameter tubular scaffolds and paves the way for tissue engineering of capillaries. Exp Cell Res. 2016 Sep 10;347(1):60-4. Epub 2016 Jul 1
  9. Larijani B, Arjmand B, Ahmadbeigi N, Falahzadeh K, Soleimani M, Sayahpour FA, Aghayan HR. A simple and cost-effective method for isolation and expansion of human fetal pancreas derived mesenchymal stem cells. Arch Iran Med. 2015 Nov;18(11):770-5. doi: 0151811/AIM.008.
  10. Taghizadeh, Mahmoudreza, Sajad Ahmadizad, and Mahmood Naderi. "Effects of endurance training on hsa-miR-223, P2RY 12 receptor expression and platelet function in type 2 diabetic patients." Clinical Hemorheology and Microcirculation Preprint (2018): 1-9.
  11. Vosough M, Moossavi S, Mardpour S, Akhlaghpoor S, Azimian V, Jarughi N, Hosseini SE, Ashrafi M, Nikfam S, Aghdami N, Malekzadeh R, Mohamadnejad M, Baharvand H. Repeated Intraportal Injection of Mesenchymal Stem Cells in Combination with Pioglitazone in Patients with Compensated Cirrhosis: A Clinical Report of Two Cases. Arch Iran Med. 2016 Feb;19(2):131-6.
  12. Mohamadnejad M, Vosough M, Moossavi S, Nikfam S, Mardpour S, Akhlaghpoor S, Ashrafi M, Azimian V, Jarughi N, Hosseini SE, Moeininia F, Bagheri M, Sharafkhah M, Aghdami N, Malekzadeh R, Baharvand H.. Intraportal Infusion of Bone Marrow Mononuclear or CD133+ Cells in Patients With Decompensated Cirrhosis: A Double-Blind Randomized Controlled Trial. Stem Cells Transl Med 2016 Jan;5(1):87-94
  13. V Haghpanah, P Fallah, M Naderi, R Tavakoli, M Soleimani, B Larijani. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma. Life Sciences. 2016
  14. Zarifeh Heidary, Jafar Ghaisari, Shiva Moein, Mahmood Naderi, Yousof Gheisari. Stochastic Petri Net Modeling of Hypoxia Pathway Predicts a Novel Incoherent Feed-Forward Loop Controlling SDF-1 Expression in Acute Kidney Injury. NanoBioscience, IEEE Transactions on. 2015
  15. Vahid Haghpanah, Parviz Fallah, Rezvan Tavakoli, Mahmood Naderi, Hilda Samimi, Masoud Soleimani, Bagher Larijani. Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer. Tumor Biology (2015): 1-10
  16. Seyed Hamid Aghaee-Bakhtiari, Ehsan Arefian, Mahmood Naderi, Farshid Noorbakhsh, Vahideh Nodouzi, Mojgan Asgari, Pezhman Fard-Esfahani, Reza Mahdian, Masoud Soleimani. MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches. Tumor Biology.2015.
  17. Amir Azimian, Seyed Asghar Havaei, Reza Besharati, Kiarash Ghazvini, Mahsa Khosrojerdi, Mahmood Naderi, Siamak Mirab Samiee. Isolation of PVL/ACME-Positive, Community Acquired, Methicillin Resistant Staphylococcus aureus(USA300) from Iran. J Med Microbiol Infec Dis. 2014
  18. Mohsen Khorashadizadeh, Masoud Soleimani, Hossein Khanahmad, Ali Fallah, Mahmood Naderi, Mohammadreza Khorramizadeh. Bypassing the need for pre-sensitization of cancer cells for anticancer TRAIL therapy with secretion of novel cell penetrable form of Smac from hA-MSCs as cellular delivery vehicle. Tumor Biology. 2015.
  19. Fakher E, seyedjafari E,Ahmadbeigi N. Osteogenic Differentiation of Mesenchymal Stem cells in their Native Niche Kike Environment . International Journal of Stem Cell Research and Transplantation. (2015) ISSN 2328-3548
  20. Mohamadnejad M, Alimoghaddam K, Bagheri M, Ashrafi M, Abdollahzadeh L, Akhlaghpoor S, Bashtar M, Ghavamzadeh A, Malekzadeh R.Liver Int. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis. 2013 Nov;33(10):1490-6.
  21. Mohamadnejad M, Ashrafi M, Alimoghaddam K, Vosough M, Mardpour S, Azimian V, Aghdami N, Bagheri M, Abdollahzadeh L, Bashtar M, Akhlaghpoor S, Ghavamzadeh A, Baharvand H, Malekzadeh R. Surveillance for hepatocellular carcinoma after autologous stem cell transplantation in cirrhosis.Middle East J Dig Dis. 2012 Jul;4(3):145-9
  22.  Gholamrezanezhad A, Mirpour S, Bagheri M, Mohamadnejad M, Alimoghaddam K, Abdolahzadeh L, Saghari M, Malekzadeh R. In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl Med Biol. 2011 Oct;38(7):961-7
  23. Pournasr B, Mohamadnejad M, Bagheri M, Aghdami N, Shahsavani M, Malekzadeh R, Baharvand H. In vitro differentiation of human bone marrow mesenchymal stem cells into hepatocyte-like cells. Arch Iran Med. 2011 Jul;14(4):244-9.
  24. Mohamadnejad M, Sohail MA, Watanabe A, Krause DS, Swenson ES, Mehal WZ. Adenosine inhibits chemotaxis and induces hepatocyte-specific genes in bone marrow mesenchymal stem cells. Hepatology. 2010 Mar;51(3):963-73.
  25. Malekzadeh R, Mohamadnejad M, Alimoghaddam K, Bagheri M, Baharvand H, Ghavamzadeh A. Cell-based regenerative therapy as an alternative to liver transplantation for end-stage liver disease: experience from iran. Int J Organ Transplant Med. 2010;1(1):21-7
  26.  Mohamadnejad M, Swenson ES. Induced pluripotent cells mimicking human embryonic stem cells. Arch Iran Med. 2008 Jan;11(1):125-8
  27. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, Baharvand H, Ghavamzadeh A, Malekzadeh R.Arch Iran Med. 2007 Oct;10(4):459-66. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.
  28. Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, Zare Mehrjardi N, Kazemi Ashtiani S, Malekzadeh R, Baharvand H. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol. 2007 Jun 28;13(24):3359-63.
مطالب مشابه